The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Business

23andMe to delist from Nasdaq, deregister with SEC

by admin May 29, 2025
May 29, 2025
23andMe to delist from Nasdaq, deregister with SEC

23andMe on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange Commission, according to a release.

The move comes after Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million.

The drugmaker came out on top following a bankruptcy auction for 23andMe, a once high-flying genetic testing company that filed for Chapter 11 bankruptcy protection in March.

23andMe said it will file a Form 25 Notification of Delisting with the SEC on or around June 6, which would subsequently remove the stock from listing and registering with the Nasdaq.

The company said the Nasdaq had originally informed the company that a Form 25 would be filed in March, but since the exchange has not yet submitted the filing, 23andMe is doing so voluntarily.

23andMe exploded into the mainstream because of its at-home DNA testing kits that allowed customers to examine their genetic profiles. At its peak, the company was valued at around $6 billion.

But after going public via a merger with a special purpose acquisition company in 2021, the company struggled to generate recurring revenue and stand up viable research or therapeutics businesses.

Regeneron’s deal is still subject to approval by the U.S. Bankruptcy Court for the Eastern District of Missouri. Pending approval, it’s expected to close in the third quarter of this year.

This post appeared first on NBC NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Dick’s Sporting Goods stands by full-year guidance — even with tariffs looming
next post
Platinum Price Breaks Out as Chinese Demand and Global Shortfalls Ignite Rally

Related Posts

Nvidia says it is not sending GPU designs...

May 17, 2025

Amazon plans to launch discount store in bid...

June 28, 2024

Philip Morris to invest $232 million to expand...

August 30, 2024

Berkshire Hathaway employee wins $1 million in Warren...

March 27, 2025

Getty Images to buy Shutterstock as part of...

January 9, 2025

Payments app Zelle begins refunds for customers hurt...

November 15, 2023

Dick’s Sporting Goods stands by full-year guidance —...

May 29, 2025

NFL-backed group lines up ‘Sunday Ticket’ streaming for...

July 5, 2024

Netflix maintained its 2025 guidance. That may not...

April 21, 2025

Pepsi sued by federal regulators for giving Walmart...

January 18, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,392)
    • Investing (3,347)
    • Politics (4,526)
    • World (4,460)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved